[1]Espejel S, Eckardt S, Harbell J, et al. Parthenogenetic embryonic stem cells are an effective cell source fortherapeutic liver repopulation[J]. Stem Cells, 2014, 32(7):1983-1988.
[2]Liu Y, Ye X, Mao L, et al. Transplantation of parthenogenetic embryonic stem cells ameliorates cardiac dysfunction and remodelling after myocardial infarction[J]. Cardiovasc Res, 2013, 97(2):208-218.
[3]Ouyang Q, Lin G, Zhou XY, et al. Comparison of the differentiation capability between human parthenogenetic embryonic stem cells and normal embryonic stem cells[J]. Acta Anatomic Sinica, 2010, 3(6):785-789. (in Chinese)
欧阳琦,林戈,周晓樱,等. 人孤雌胚胎干细胞与正常胚胎干细胞分化能力的比较[J].解剖学报, 2010,3(6):785-789.
[4]Cordeiro A, Neto AP, Carvalho F, et al. Relevance of genomic imprinting in intrauterine human growth expression of CDKN1C, H19, IGF2, KCNQ1 and PHLDA2 imprinted genes[J]. J Assist Reprod Genet, 2014,31(10):1361-1368.
[5]Zhu JQ, Si YJ, Cheng LY, et al. Sodium fluoride disrupts DNA methylation of H19 and Peg3 imprinted genes during the early development of mouse embryo[J]. Arch Toxicol, 2014, 88(2):241-248.
[6]Smeester L, Yosim AE, Nye MD, et al. Imprinted genes and the environment: links to the toxic metals arsenic, cadmium, lead and mercury[J]. Genes (Basel), 2014, 5(2):477-496.
[7]Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult broblast cultures by dened factors[J].Cell, 2006, 126(4):663-676.
[8]Patel D, Ellis R, Howard B, et al. Analysis of IGF and IGFBP as prognostic serum biomarkers for adrenocortical carcinoma[J]. Ann Surg Oncol, 2014,21(11):3541-3547.
[9]Dowdy SC, Gostout BS, Shridhar V, et al. Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines[J]. Gynecol Oncol, 2005, 99(1):126-134.
[10]Goto M, Saito Y, Honda R, et al. Episodic tremors representing cortical myoclonus are characteristic in Angelman syndrome due to UBE3A mutations [J]. Brain Dev, 2015, 37(2):216-222.
[11]Anderlid BM, Lundin J, Malmgren H, et al. Small mosaic deletion encompassing the snoRNAs and SNURF-SNRPN results in an atypical Prader-Willi syndrome phenotype[J]. Am J Med Genet A, 2014, 164A(2):425-431.
[12]Rieusset A, Schaller F, Unmehopa U, et al. Stochastic loss of silencing of the imprinted Ndn/NDN allele, in a mouse model and humans with prader-willi syndrome, has functional consequences[J]. PLoS Genet, 2013, 9(9):e1003752.
[13]Shan ZY, Wu YS, Shen XH, et al. Aggregation of pre-implantation embryos improves establishment of parthenogenetic stem cells and expression of imprinted genes[J]. Dev Growth Differ, 2012, 54(4):481-488.
[14]Revazova ES, Turovets NA, Kochetkova OD, et al. Patient-specific stem cell lines derived from human parthenogenetic blastocysts[J]. Cloning Stem Cells, 2007, 9(3):432-449.
[15]Daughtry B, Mitalipov S. Concise review: parthenote stem cells for regenerative medicine: genetic, epigenetic, and developmental features[J]. Stem Cells Transl Med, 2014, 3(3):290-298.
[16]Durak O, Tsai LH. Human induced pluripotent stem cells: now open to discovery[J]. Cell Stem Cell, 2014, 15(1):4-6.
[17]Vassena R, Montserrat N, Carrasco Canal B, et al. Accumulation of instability in serial differentiation and reprogramming of parthenogenetic human cells[J]. Hum Mol Genet, 2012, 21(15):3366-3373. |